Charles River Laboratories International Inc (CRL)
Industry Diagnostics & Research
This stock can be held in an Investment Account
Sell
$176.00
Buy
$200.00
$-4.45 (-2.40%)
Prices updated at 06 Jun 2026, 00:32 EDT
| Prices minimum 15 mins delay
Prices in USD
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company’s research model & services segment is the leading provider of animal models for laboratory testing, which breeds and deli ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Diagnostics & Research
Chairman
Dr. Martin W. Mackay, PhD
CEO
Ms. Birgit Girshick
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
19,700
Head office
251 Ballardvale Street
Wilmington
United States
01887
Key personnel
Owner name | Salary |
|---|---|
Mr. Glenn G. Coleman, C.P.A. Corporate Executive Vice President and Chief Financial Officer | - |
Mr. James C. Foster Director | 1.55m |
Dr. Martin W. Mackay, PhD Chairman of the Board | 0.11m |
Mr. Michael Gunnar Knell Corporate Senior Vice President and Chief Accounting Officer | 0.45m |
Ms. Victoria L. Creamer Corporate Executive Vice President | 0.55m |
Ms. Birgit Girshick Chief Executive Officer and Director | 0.76m |
Dr. Craig B. Thompson,M.D. Independent Director | 0.09m |
Ms. Virginia M. Wilson Independent Director | 0.09m |
Mr. Paul W. Graves Independent Director | 0.09m |
Mr. Mark Joseph Enyedy Independent Director | 0.07m |
Dr. Nancy C. Andrews, M.D.,PhD Independent Director | 0.09m |
Mr. Joseph W. LaPlume Corporate Executive Vice President, Corporate Development and Strategy | 0.57m |
Mr. George Llado, Sr Independent Director | 0.07m |
Mr. Steven K. Barg Independent Director | 0.07m |
Ms. Shannon M. Parisotto Corporate Executive Vice President | - |
Ms. Reshema Kemps-Polanco Independent Director | 0.09m |
Mr. Abraham Ceesay Director | 0.07m |
Mr. Mark Mintz Corporate Executive Vice President and Chief Information Officer & Global Shared Services | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Vanguard Group Inc | 5,887,175 |
| BlackRock Inc | 3,859,100 |
| Fidelity Management & Research Company LLC | 3,764,546 |
| FMR Inc | 3,456,244 |
| Fidelity Management and Research Company | 3,456,244 |
Director dealings
Date | Action |
|---|---|
| 06 Nov 2025 | - |
| 22 Aug 2025 | - |
| 18 Aug 2025 | - |
| 07 Aug 2025 | - |
| 05 Jun 2025 | - |
| 02 Jun 2025 | - |
| 02 Jun 2025 | - |
| 02 Jun 2025 | - |
| 02 Jun 2025 | - |
| 02 Jun 2025 | - |
| 02 Jun 2025 | - |
| 02 Jun 2025 | - |
| 30 May 2025 | - |
| 01 Jun 2025 | - |
| 31 May 2025 | - |
| 30 May 2025 | - |
| 31 May 2025 | - |
| 30 May 2025 | - |
| 30 May 2025 | - |
| 31 May 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
